Immunofluorescence staining also confirmed elevated expression of the glial cell marker Iba1 in the DRG following CIP induction, which was attenuated by AI treatment and Trpv1 gene deletion (Figure 6B). The gene discussed is TRPV1; the disease is hereditary sensory and autonomic neuropathy.